XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock Incentive Plan | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Stock Incentive Plan | 17. Stock Incentive Plan The Company maintains the Autoliv, Inc. 1997 Stock Incentive Plan, as amended (the “Stock Incentive Plan”), pursuant to which it has granted to eligible employees and non-employee directors stock options (SOs), restricted stock units (RSUs) and performance shares (PSUs). The fair value of the RSUs and PSUs is calculated as the grant date fair value of the shares expected to be issued. The RSUs and PSUs granted in 2024, 2023 and 2022 entitle the grantee to receive dividend equivalents in the form of additional RSUs and PSUs subject to the same vesting conditions as the underlying RSUs and PSUs. For the grants made during 2024, 2023 and 2022, the fair value of a RSU and a PSU was calculated by using the closing stock price on the grant date and, with respect to a PSU, assumed target performance. The grant date fair value for the RSUs and PSUs granted during 2024 was approximately $7 million and approximately $8 million, respectively. Pursuant to the Company’s non-employee director compensation policy effective May 1, 2024, the Company’s non-employee directors receive an annual RSU grant having a grant date value equal to $152,500 and the Chairman of the Board of Directors also receives an additional annual RSU grant having a grant date value equal to $90,000. All RSUs granted to non-employee directors vest in one installment on the earlier of the next AGM or the first anniversary of the grant date, in each case subject to the grantee’s continued service as a non-employee director on the vesting date with limited exceptions. The RSUs granted to the Company’s non-employee directors entitle the grantee to receive dividend equivalents in the form of additional RSUs subject to the same vesting conditions as the underlying RSUs. The grant date fair value for the RSUs granted in 2024 to the Company’s non-employee directors was approximately $2 million. The source of the shares issued upon vesting of awards is generally from treasury shares. The Stock Incentive Plan provides for the issuance of up to 9,585,055 common shares for awards. At December 31, 2024, 7,156,026 of these shares have been issued for awards and 2,429,029 shares remain available for future grants. In 2015 and earlier, stock awards were granted in the form of SOs and RSUs. All SOs were granted for 10-year terms, had an exercise price equal to the fair market value per share of common stock at the date of grant, and became exercisable after one year of continued employment following the grant date. The average grant date fair values of SOs were calculated using the Black-Scholes valuation model. The Company used historical exercise data for determining the expected life assumption. Expected volatility was based on historical and implied volatility. All outstanding SOs as of December 31, 2024 have since been exercised or expired. The Company recorded approximately $16 million, $14 million and $4 million stock-based compensation expense related to RSUs and PSUs for 2024, 2023 and 2022, respectively. The total compensation cost related to non-vested awards not yet recognized is $17 million for RSUs and PSs and the weighted average period over which this cost is expected to be recognized is approximately 1.7 years. There are no remaining unrecognized compensation costs associated with SOs. Information on the number of RSUs, PSUs and SOs related to the Stock Incentive Plan during the period of 2022 to 2024 is as follows.
RSUs |  | 2024 |  |  | 2023 |  |  | 2022 |
Weighted average fair value at grant date |  | $ | 112.16 |  |  | $ | 91.81 |  |  | $ | 87.56 |
Outstanding at beginning of year |  |  | 189,966 |  |  |  | 200,764 |  |  |  | 218,268 |
Granted |  |  | 64,601 |  |  |  | 96,243 |  |  |  | 85,985 |
Shares issued |  |  | (75,068 | ) |  |  | (94,055 | ) |  |  | (84,848 | )
Cancelled/Forfeited/Expired |  |  | (5,352 | ) |  |  | (12,986 | ) |  |  | (18,641 | )
Outstanding at end of year |  |  | 174,147 |  |  |  | 189,966 |  |  |  | 200,764 |
The aggregate intrinsic value for RSUs outstanding at December 31, 2024 was approximately $16 million.
PSUs |  | 2024 |  |  | 2023 |  |  | 2022 |
Weighted average fair value at grant date |  | $ | 109.41 |  |  | $ | 91.80 |  |  | $ | 88.05 |
Outstanding at beginning of year |  |  | 111,881 |  |  |  | 101,828 |  |  |  | 179,311 |
Change in performance conditions |  |  | 147,022 |  |  |  | 18,211 |  |  |  | (69,924 | )
Granted |  |  | 79,712 |  |  |  | 93,962 |  |  |  | 82,914 |
Shares issued |  |  | (49,509 | ) |  |  | (26,331 | ) |  |  | (64,397 | )
Cancelled/Forfeited/Expired |  |  | (9,801 | ) |  |  | (75,789 | ) |  |  | (26,076 | )
Outstanding at end of year |  |  | 279,305 |  |  |  | 111,881 |  |  |  | 101,828 |
The PSUs granted include assumptions regarding the ultimate number of shares that will be issued based on the probability of achievement of the performance conditions. Changes in those assumptions result in changes in the estimated shares to be issued which is reflected in the “Change in performance conditions” line above.
SOs |  | Number of options |  |  | Weighted average exercise price |
Outstanding at December 31, 2021 |  |  | 49,875 |  |  |  | 68.71 |
Exercised |  |  | (8,614 | ) |  |  | 59.28 |
Cancelled/Forfeited/Expired |  |  | (10,150 | ) |  |  | 70.40 |
Outstanding at December 31, 2022 |  |  | 31,111 |  |  |  | 70.77 |
Exercised |  |  | (15,537 | ) |  |  | 65.12 |
Cancelled/Forfeited/Expired |  |  | (485 | ) |  |  | 58.63 |
Outstanding at December 31, 2023 |  |  | 15,089 |  |  |  | 76.97 |
Exercised |  |  | (10,777 | ) |  |  | 76.53 |
Cancelled/Forfeited/Expired |  |  | (915 | ) |  |  | 69.41 |
Outstanding at December 31, 2024 |  |  | 3,397 |  |  |  | 80.40 |
OPTIONS EXERCISABLE |  |  |  |  |  |
At December 31, 2022 |  |  | 31,111 |  |  | $ | 70.77 |
At December 31, 2023 |  |  | 15,089 |  |  |  | 76.97 |
At December 31, 2024 |  |  | 3,397 |  |  |  | 80.40 |
The following summarizes information about SOs outstanding and exercisable at December 31, 2024:
EXERCISE PRICE |  | Number outstanding & exercisable |  |  | Remaining contract life (in years) |  |  | Weighted average exercise price |
$80.40 |  |  | 3,397 |  |  |  | 0.13 |  |  |  | 80.40 |
|  |  | 3,397 |  |  |  | 0.13 |  |  |  | 80.40 |
The total aggregate intrinsic value, which is the difference between the exercise price and $92.98 (closing price per share at December 31, 2024), for all “in the money” SOs, both outstanding and exercisable as of December 31, 2024, was immaterial.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration